Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early ...
Adaptive deep brain stimulation has virtually eliminated the most debilitating motor symptoms for some Parkinson’s patients ...
A project led by scientists at the University of Dundee’s School of Life Sciences and School of Medicine has been selected for the 2025 SPARK NS Translational award, aimed at accelerating scientific d ...
An update to the traditional deep brain stimulation device enables adaptive pulses of electricity that help to lessen the symptoms of Parkinson’s disease and inform future research.
The proteins were gathered from ... Researchers Identify a Potential Biomarker of Parkinson's Disease Progression Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's ...
Buntanetap showed statistically significant improvements in every primary and secondary endpoint in the per-protocol population.
At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD), Roche announced topline results ...
It's an honor to be a part of this process to, as a basic scientist, be able to play a small role in improving the lives of ...
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback